Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $36.71 | $14.39 | 154.99% | 89.52x | 48.19x | 11.86x | 21.07x | 1.15x | -$59.24M | -1.10% | $276.43M | 1.88 | $5.95B | 60.97 | ||
| CORT | CORCEPT THERAPEUTICS INC | $88.15 | $30.70 | 187.13% | 69.96x | 76.82x | 12.82x | 14.61x | 1.43x | $180.28M | 1.96% | $635.79M | 6.11 | $9.19B | 89.98 | ||
| CRMD | CORMEDIX INC | $11.34 | $13.19 | -14.06% | 43.62x | 6.19x | 8.96x | 6.69x | 0.37x | -$13.63M | -1.84% | $114.89M | 1.76 | $703.32M | 39.81 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $38.49 | $5.51 | 598.15% | 641.50x | 39.08x | 5.34x | 5.76x | 2.81x | $66.49M | 2.35% | $495.01M | 6.74 | $2.67B | 140.21 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.98 | $68.04 | 1.38% | 15.40x | 11.80x | 7.10x | 24.25x | 0.62x | $540.69M | 6.46% | $332.75M | 2.74 | $9.52B | 12.02 | ||
| KRYS | KRYSTAL BIOTECH INC | $183.36 | $92.99 | 97.18% | 35.88x | 38.80x | 14.76x | 5.10x | 1.10x | $185.88M | 3.51% | $1.04B | 36.00 | $4.96B | 28.36 | ||
| ARGX | ARGENX SE | $800.00 | $218.07 | 266.86% | 31.97x | 50.83x | 25,806.45x | 6.81x | 4.29x | $467.72M | 0.96% | $7.17B | 117.50 | $46.42B | 57.22 | ||
| INVA | INNOVIVA INC | $17.48 | $17.44 | 0.21% | 28.66x | 8.83x | 2.97x | 1.54x | 0.48x | $196.35M | 17.87% | $714.82M | 11.37 | $1.15B | 9.19 | ||
| VCEL | VERICEL CORP | $32.44 | $5.30 | 511.57% | 231.71x | 200.25x | 6.56x | 5.34x | 2.73x | -$8.30M | -0.51% | $306.81M | 6.09 | $1.66B | 75.07 | ||
| RPRX | ROYALTY PHARMA PLC | $36.07 | $50.86 | -29.08% | 15.61x | 7.91x | 6.63x | 2.21x | 0.37x | $2.11B | 13.83% | $9.50B | 22.44 | $28.41B | 22.07 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $11.35 | $5.57 | 103.65% | 25.80x | 17.62x | 5.88x | 4.46x | 1.44x | $92.38M | 6.04% | $335.30M | 2.49 | $1.52B | 17.61 | ||
| INCY | INCYTE CORP | $86.85 | $63.77 | 36.19% | 19.65x | 16.93x | 3.67x | 4.07x | 0.87x | $958.08M | 5.69% | $4.17B | 21.50 | $15.04B | 11.10 | ||
| EXEL | EXELIXIS INC | $40.09 | $27.20 | 47.36% | 18.65x | 17.14x | 4.90x | 5.31x | 1.04x | $754.07M | 6.90% | $2.03B | 7.46 | $10.81B | 13.00 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.41 | $0.41 | 1,697.74% | 185.25x | 57.00x | 6.46x | 7.76x | 15.86x | $73.00k | 0.01% | $92.03M | 1.03 | $678.58M | 68.83 | ||
| ADMA | ADMA BIOLOGICS INC | $14.66 | $9.70 | 51.07% | 16.66x | 23.27x | 7.46x | 8.78x | 1.23x | $65.77M | 1.86% | $398.33M | 1.65 | $3.48B | 21.35 | ||
| MDXG | MIMEDX GROUP INC | $7.21 | $4.83 | 49.18% | 32.77x | 25.30x | 2.93x | 4.92x | 0.77x | $57.13M | 5.37% | $216.62M | 1.47 | $966.38M | 17.77 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $27.28 | $37.48 | -27.22% | 8.63x | 8.66x | 2.03x | 2.03x | 0.55x | $258.73M | 16.50% | $773.08M | 13.45 | $1.20B | 4.51 | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $14.41 | $11.06 | 30.31% | 19.74x | -16.19x | 0.93x | -2.89x | 0.80x | -$63.66M | -36.22% | -$35.04M | -2.87 | $139.95M | 5.63 | ||
| TECH | BIO-TECHNE CORP | $62.95 | $19.73 | 219.06% | 133.94x | 35.72x | 8.13x | 5.10x | 1.40x | $256.55M | 2.59% | $1.92B | 12.18 | $10.07B | 46.45 | ||
| VCYT | VERACYTE INC | $36.00 | $9.75 | 269.20% | 83.72x | 41.74x | 6.06x | 2.36x | 1.88x | $78.45M | 2.79% | $1.19B | 15.31 | $2.68B | 42.55 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.43 | $43.85 | 26.40% | 16.11x | 14.90x | 3.47x | 1.77x | 0.89x | $694.91M | 6.53% | $6.03B | 31.41 | $10.03B | 10.73 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $403.30 | $140.22 | 187.62% | 28.56x | 25.40x | 9.07x | 6.02x | 2.67x | $3.50B | 3.38% | $17.18B | 66.91 | $99.96B | 21.77 | ||
| GMAB | GENMAB A | $33.56 | $17.38 | 93.14% | 17.03x | 19.34x | 6.49x | 4.06x | 2.20x | $938.44M | 4.36% | $5.30B | 8.26 | $20.37B | 11.20 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $20.84 | $18.97 | 9.86% | 12.05x | 9.52x | 4.56x | 2.98x | 0.90x | $274.72M | 10.79% | $856.03M | 7.01 | $1.90B | 6.13 | ||
| NVO | NOVO NORDISK A S | $59.63 | $30.50 | 95.51% | 15.31x | 15.62x | 5.47x | 10.15x | 3.00x | $10.18B | 3.82% | $26.22B | 5.87 | $278.86B | 11.40 | ||
| MNKD | MANNKIND CORP | $5.76 | $1.00 | 478.04% | 52.36x | 64.00x | 5.82x | -32.11x | 6.26x | $28.79M | 1.63% | -$55.04M | -0.18 | $2.00B | 25.25 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.